Breaking News Instant updates and real-time market news.

NLSN

Nielsen

$25.58

-0.93 (-3.51%)

06:34
10/25/18
10/25
06:34
10/25/18
06:34

Nielsen backs FY GAAP EPS view 95c-$1.00, consensus 99c

The company reiterates its full year revenue, adjusted EBITDA and GAAP net income per share guidance and is updating free cash flow. Nielsen sees FY revenue down about 1% on a constant currency basis, adjusted EBITDA margin down about 230bps and now sees free cash flow of $450M-$500M vs. prior view of $550M-$575M.

  • 25

    Oct

  • 28

    Oct

NLSN Nielsen
$25.58

-0.93 (-3.51%)

08/23/18
GSCO
08/23/18
UPGRADE
Target $25
GSCO
Neutral
Nielsen upgraded to Neutral from Sell at Goldman Sachs
Goldman Sachs analyst George Tong upgraded Nielsen Holdings to Neutral and raised his price target for the shares to $25 from $20. With activist Elliott Management pushing for a sale and increased deal activity in the Information Services sector, Tong sees increased likelihood of Nielsen being involved in a transaction. His upgrade to Neutral and price target increase come after the analyst incorporated a potential takeover into his model.
08/23/18
08/23/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Target (TGT) upgraded to Outperform from Market Perform at Telsey Advisory. 2. Deckers Brands (DECK) upgraded to Neutral from Negative at Susquehanna with analyst Sam Poser saying wholesale accounts are more positive than just a few months ago following checks with both large and small retailers. 3. Nielsen (NLSN) upgraded to Neutral from Sell at Goldman Sachs with analyst George Tong saying with activist Elliott Management pushing for a sale and increased deal activity in the Information Services sector, he sees increased likelihood of Nielsen being involved in a transaction. 4. Finisar (FNSR) upgraded to Overweight from Neutral at Piper Jaffray with analyst Troy Jensen saying China demand is returning via Huawei and ZTE (ZTCOY), Finisar is facing easy comps following five quarters of depressed demand and the upcoming 400G cycle should provide a tailwind in 2019. 5. Coca-Cola Amatil (CCLAY) upgraded to Equal Weight from Underweight at Morgan Stanley. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/23/18
08/23/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. ROSENBLATT BOOSTS AMD PRICE TARGET TO STREET HIGH: Rosenblatt analyst Hans Mosesmann raised his price target for AMD (AMD) shares to $30 from $27. Mosesmann's new price target represents the high among Wall Street sell-side analysts. Following the meetings, Mosesmann has renewed conviction in AMD's multi-year double digit growth profile. Further, he's impressed by the analysis investors are doing in the name after years of disregard. AMD is up 4.1% in late morning trading. CANTOR CUTS AETNA TO NEUTRAL: Cantor Fitzgerald analyst Steven Halper downgraded Aetna (AET) to Neutral from Overweight with a price target of $202. The stock now trades at just a 4.6% discount to the implied CVS Health (CVS) acquisition value of about $207 per share, Halper said. He believes the narrowed deal spread reflects an increased likelihood of regulatory approval. Halper cites limited potential upside for his downgrade of Aetna to Neutral. NIELSEN UPGRADED TO NEUTRAL AT GOLDMAN: Goldman Sachs analyst George Tong upgraded Nielsen Holdings (NLSN) to Neutral and raised his price target for the shares to $25 from $20. With activist Elliott Management pushing for a sale and increased deal activity in the Information Services sector, Tong sees increased likelihood of Nielsen being involved in a transaction. His upgrade to Neutral and price target increase come after the analyst incorporated a potential takeover into his model. Nielsen is up 3.3% in late morning trading. IMPERIAL SEES SUBSCRIBER UPSIDE FOR NETFLIX: Imperial Capital analyst David Miller believes Netflix's (NFLX) experiment with ending billing through Apple's (AAPL) app store in 33 countries outside the U.S. likely implies upside to its Q3 international subscriber guidance. The analyst said he has a tough time believing that Netflix would "experiment" with billing infrastructure mid-quarter if it did not believe that its international subscriber levels were trending ahead of guidance. As such, Miller raised his Q3 international subscriber estimate to 4.46M from 4.35M. He kept an Outperform rating on Netflix with a $494 price target. TARGET GETS UPGRADE AND DOWNGRADE: Target (TGT) was upgraded to Outperform from Market Perform at Telsey Advisory, and downgraded to Peer Perform from Outperform at Wolfe Research.
08/29/18
PIPR
08/29/18
NO CHANGE
PIPR
Piper calls IHS Markit, S&P Global top picks in Information Services
Piper Jaffray analyst Peter Appert calls IHS Markit (IHS) and S&P Global (SPGI) his top picks in the Information Services sector. Dun & Bradstreet's (DNB) pending sale to a private equity group and Nielsen's (NLSN) strategic review refocuses investor attention on M&A activity in the sector, Appert tells investors in a research note. He says that while "rich" transaction values provide an "intriguing valuation backstop for the group," he continues to focus on operating fundamentals as the key driver of stock performance.

TODAY'S FREE FLY STORIES

UPS

UPS

$97.22

-2.47 (-2.48%)

, FDX

FedEx

$156.36

-4.52 (-2.81%)

13:28
06/25/19
06/25
13:28
06/25/19
13:28
Periodicals
UPS says won't join FedEx's suit against U.S., Reuters says »

UPS (UPS) said it does…

UPS

UPS

$97.22

-2.47 (-2.48%)

FDX

FedEx

$156.36

-4.52 (-2.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 25

    Jun

  • 26

    Jun

  • 24

    Jul

  • 30

    Jul

  • 31

    Jul

  • 13

    Nov

EOLS

Evolus

$14.26

0.57 (4.16%)

, AGN

Allergan

$164.07

34.42 (26.55%)

13:26
06/25/19
06/25
13:26
06/25/19
13:26
Recommendations
Evolus, Allergan, AbbVie, Revance, Aerie Pharmaceuticals, TherapeuticsMD, Kala Pharmaceuticals analyst commentary  »

Evolus can benefit from…

EOLS

Evolus

$14.26

0.57 (4.16%)

AGN

Allergan

$164.07

34.42 (26.55%)

ABBV

AbbVie

$66.52

-11.89 (-15.16%)

RVNC

Revance

$12.15

0.59 (5.10%)

AERI

Aerie Pharmaceuticals

$30.34

0.13 (0.43%)

TXMD

TherapeuticsMD

$2.58

0.06 (2.38%)

KALA

Kala Pharmaceuticals

$5.78

0.2 (3.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 25

    Jun

  • 10

    Jul

  • 10

    Jul

  • 11

    Jul

  • 11

    Jul

  • 31

    Jul

  • 01

    Aug

  • 15

    Aug

  • 16

    Sep

TDG

TransDigm

$490.64

-0.47 (-0.10%)

13:25
06/25/19
06/25
13:25
06/25/19
13:25
Hot Stocks
DoD: TransDigm 'negotiating excessive profits' on contracts for spare parts »

The Department of Defense…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSN

Tyson Foods

$82.69

1.85 (2.29%)

13:25
06/25/19
06/25
13:25
06/25/19
13:25
Options
Tyson Foods call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:25
06/25/19
06/25
13:25
06/25/19
13:25
General news
Fed Chair Powell repeated the phrase from the FOMC that the Fed is "closely monitoring »

Fed Chair Powell repeated…

IBKR

Interactive Brokers

$52.66

0.21 (0.40%)

, ETFC

E-Trade

$44.43

-0.14 (-0.31%)

13:25
06/25/19
06/25
13:25
06/25/19
13:25
Conference/Events
Sandler O'Neill financial analyst to hold an analyst/industry conference call »

Financial Analyst Repetto…

IBKR

Interactive Brokers

$52.66

0.21 (0.40%)

ETFC

E-Trade

$44.43

-0.14 (-0.31%)

SCHW

Charles Schwab

$39.22

0.07 (0.18%)

AMTD

TD Ameritrade

$48.32

0.23 (0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 23

    Jul

  • 06

    Aug

  • 27

    Oct

13:20
06/25/19
06/25
13:20
06/25/19
13:20
General news
FX Action: The DXY rallied »

FX Action: The DXY…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
06/25/19
06/25
13:17
06/25/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
06/25/19
06/25
13:16
06/25/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HUYA

Huya

$23.90

-1.52 (-5.98%)

13:15
06/25/19
06/25
13:15
06/25/19
13:15
Options
HUYA put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:15
06/25/19
06/25
13:15
06/25/19
13:15
General news
Treasury's $40 B 2-year auction was mixed as a confluence of factors impacted »

Treasury's $40 B…

ASOMY

Asos

$0.00

(0.00%)

13:11
06/25/19
06/25
13:11
06/25/19
13:11
Downgrade
Asos rating change  »

Asos downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$33.46

0.28 (0.84%)

13:08
06/25/19
06/25
13:08
06/25/19
13:08
On The Fly
Fly Intel: What to watch in Micron's earnings report »

Micron (MU) is scheduled…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 09

    Jul

13:08
06/25/19
06/25
13:08
06/25/19
13:08
General news
2-Yr Note Auction Coupon Rate data reported »

2-Yr Note Auction Coupon…

13:07
06/25/19
06/25
13:07
06/25/19
13:07
General news
2-Yr Note Auction Total Amount data reported »

2-Yr Note Auction Total…

MDR

McDermott

$8.82

0.6 (7.30%)

13:05
06/25/19
06/25
13:05
06/25/19
13:05
Options
McDermott call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$56.48

-0.24 (-0.42%)

13:03
06/25/19
06/25
13:03
06/25/19
13:03
Hot Stocks
Oracle announces 'simplified' analytics product offering »

Oracle said in a press…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLF

Herbalife Nutrition

$43.03

0.82 (1.94%)

12:55
06/25/19
06/25
12:55
06/25/19
12:55
Options
Herbalife put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:55
06/25/19
06/25
12:55
06/25/19
12:55
General news
Fed dove, and dissenter Bullard doesn't believe a 50 bp easing is necessary right now »

Fed dove, and dissenter…

AGN

Allergan

$163.79

34.14 (26.33%)

, ABBV

AbbVie

$66.51

-11.905 (-15.18%)

12:50
06/25/19
06/25
12:50
06/25/19
12:50
Upgrade
Allergan, AbbVie rating change at Barclays »

Allergan upgraded to…

AGN

Allergan

$163.79

34.14 (26.33%)

ABBV

AbbVie

$66.51

-11.905 (-15.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 16

    Sep

AG

First Majestic

$7.98

-0.04 (-0.50%)

12:45
06/25/19
06/25
12:45
06/25/19
12:45
Options
First Majestic call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:45
06/25/19
06/25
12:45
06/25/19
12:45
General news
Breaking General news story  »

Federal Reserve Chairman…

DIS

Disney

$139.71

0.49 (0.35%)

12:42
06/25/19
06/25
12:42
06/25/19
12:42
Periodicals
MNC founder says not in talks with Disney over investment, Reuters says »

Media Nusantara Citra is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

APVO

Aptevo Therapeutics

$0.90

-0.0445 (-4.71%)

12:38
06/25/19
06/25
12:38
06/25/19
12:38
Recommendations
Aptevo Therapeutics analyst commentary  »

Aptevo IXINITY…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TDOC

Teladoc

$62.00

-0.76 (-1.21%)

12:37
06/25/19
06/25
12:37
06/25/19
12:37
Recommendations
Teladoc analyst commentary  »

Teladoc CFO hiring news…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.